Back
Innate Pharma SA Vs. Charles River Laboratories International Industry Stock Comparison
Sell
40
IPHA
Innate Pharma SA
Last Price:
$2.08
Seasonality Move:
-9.96%
Buy
55
CRL
Charles River Laboratories International
Last Price:
$138.96
Seasonality Move:
7.09%
Sell
40
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.04. The Score for IPHA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
IPHA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
-
The current Charles River Laboratories International [CRL] share price is $144.02. The Score for CRL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.04The current trend is moderately bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $144.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing slight buying pressure.
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 45.4 | Sell |
Chaikin Money Flow: | -74532 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.89 - 2.27) | Sell |
Bollinger Bands (100): | (1.79 - 2.21) | Buy |
CRL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.49 | Buy |
Relative Strength Index (14 RSI): | 62.74 | Buy |
Chaikin Money Flow: | 352094 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.44 - 132.32) | Buy |
Bollinger Bands (100): | (130.6 - 181.68) | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.29 | Sell |
20-day SMA: | 2.14 | Sell |
50-day SMA: | 2.02 | Buy |
200-day SMA: | 2.01 | Buy |
8-day EMA: | 2.25 | Sell |
20-day EMA: | 2.16 | Sell |
50-day EMA: | 2.06 | Sell |
200-day EMA: | 2.07 | Sell |
CRL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 132.19 | Buy |
20-day SMA: | 119.53 | Buy |
50-day SMA: | 139.83 | Buy |
200-day SMA: | 178.2 | Sell |
8-day EMA: | 134.43 | Buy |
20-day EMA: | 124.36 | Buy |
50-day EMA: | 99.23 | Buy |
200-day EMA: | 40.83 | Buy |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.58 per share, and an increase next year of $0.66 per share.
Innate Pharma SA Technical Analysis
Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Charles River Laboratories International Technical Analysis
Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |